• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A nomogram associated with high probability of malignant nodes in the surgical specimen after trimodality therapy of patients with oesophageal cancer.三模式治疗后食管癌患者手术标本中恶性淋巴结高概率相关的列线图。
Eur J Cancer. 2012 Dec;48(18):3396-404. doi: 10.1016/j.ejca.2012.06.020. Epub 2012 Jul 31.
2
Nomograms for predicting overall and recurrence-free survival after trimodality therapy for esophageal adenocarcinoma.预测食管腺癌三模式治疗后总生存和无复发生存的列线图。
J Surg Oncol. 2021 Mar;123(4):881-890. doi: 10.1002/jso.26349. Epub 2020 Dec 17.
3
Prognostic nomogram for previously untreated patients with esophageal squamous cell carcinoma after esophagectomy followed by adjuvant chemotherapy.食管鳞状细胞癌患者接受食管切除术后辅助化疗,针对此前未接受过治疗患者的预后列线图。
Jpn J Clin Oncol. 2016 Apr;46(4):336-43. doi: 10.1093/jjco/hyv206. Epub 2016 Jan 26.
4
Lymph node harvest in esophageal cancer after neoadjuvant chemoradiotherapy.新辅助放化疗后食管癌的淋巴结清扫。
Ann Surg Oncol. 2013 Sep;20(9):3038-43. doi: 10.1245/s10434-013-2988-4. Epub 2013 Apr 28.
5
Preoperative Nomogram to Risk Stratify Patients for the Benefit of Trimodality Therapy in Esophageal Adenocarcinoma.术前列线图对食管腺癌患者进行风险分层,以获益于三联疗法。
Ann Surg Oncol. 2018 Jun;25(6):1598-1607. doi: 10.1245/s10434-018-6435-4. Epub 2018 Mar 22.
6
Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction.术前奥沙利铂、多西他赛和卡培他滨联合放化疗治疗局部食管或胃食管交界处癌的 I/II 期临床试验。
J Clin Oncol. 2010 May 1;28(13):2213-9. doi: 10.1200/JCO.2009.24.8773. Epub 2010 Mar 29.
7
Refining pathological evaluation of neoadjuvant therapy for adenocarcinoma of the esophagus.优化新辅助治疗食管腺癌的病理评估。
World J Gastroenterol. 2013 Dec 28;19(48):9282-93. doi: 10.3748/wjg.v19.i48.9282.
8
Treatment utilization and outcomes in elderly patients with locally advanced esophageal carcinoma: a review of the National Cancer Database.老年局部晚期食管癌患者的治疗利用情况及结局:美国国立癌症数据库综述
Cancer Med. 2017 Dec;6(12):2886-2896. doi: 10.1002/cam4.1250. Epub 2017 Nov 15.
9
Pre- and post-therapy nodal status equally affects survival of patients with oesophageal squamous cell carcinoma receiving preoperative chemoradiation.术前放化疗治疗的食管鳞癌患者,治疗前后的淋巴结状态同样影响生存。
Oncol Rep. 2010 May;23(5):1331-7. doi: 10.3892/or_00000768.
10
Neoadjuvant chemoradiation is associated with improved overall survival in older patients with esophageal cancer.新辅助放化疗可改善老年食管癌患者的总生存。
J Geriatr Oncol. 2018 Jan;9(1):40-46. doi: 10.1016/j.jgo.2017.08.010. Epub 2017 Sep 6.

引用本文的文献

1
Development of a Nomogram to Predict the Outcome for Patients with Soft Tissue Sarcoma.用于预测软组织肉瘤患者预后的列线图的开发。
Vet Sci. 2023 Mar 29;10(4):266. doi: 10.3390/vetsci10040266.
2
A Novel RNA-Seq-Based Model for Preoperative Prediction of Lymph Node Metastasis in Oral Squamous Cell Carcinoma.一种基于 RNA-Seq 的新型模型,用于术前预测口腔鳞状细胞癌的淋巴结转移。
Biomed Res Int. 2020 Aug 31;2020:4252580. doi: 10.1155/2020/4252580. eCollection 2020.
3
Prognostic nomogram for overall survival in upper aerodigestive tract extranodal natural killer/T-cell lymphoma, nasal type, stages IE and IIE: A SEER-based study.上呼吸道消化道结外自然杀伤/T细胞淋巴瘤(鼻型,IE期和IIE期)总生存的预后列线图:一项基于监测、流行病学和最终结果(SEER)数据库的研究
Oncol Lett. 2019 Oct;18(4):3493-3500. doi: 10.3892/ol.2019.10719. Epub 2019 Aug 6.
4
Development of a preoperative prediction nomogram for lymph node metastasis in colorectal cancer based on a novel serum miRNA signature and CT scans.基于新型血清 miRNA 特征和 CT 扫描的结直肠癌淋巴结转移术前预测列线图的建立。
EBioMedicine. 2018 Nov;37:125-133. doi: 10.1016/j.ebiom.2018.09.052. Epub 2018 Oct 9.
5
Prediction and diagnosis of interval metastasis after neoadjuvant chemoradiotherapy for oesophageal cancer using F-FDG PET/CT.利用 F-FDG PET/CT 预测和诊断新辅助放化疗后食管癌的间隔转移。
Eur J Nucl Med Mol Imaging. 2018 Sep;45(10):1742-1751. doi: 10.1007/s00259-018-4011-6. Epub 2018 Apr 16.
6
A nomogram based on phosphorylated AKT1 for predicting locoregional recurrence in patients with oesophageal squamous cell carcinoma.一种基于磷酸化AKT1的列线图,用于预测食管鳞状细胞癌患者的局部区域复发。
J Cancer. 2017 Oct 17;8(18):3755-3763. doi: 10.7150/jca.20828. eCollection 2017.
7
Nomograms in oncology: more than meets the eye.肿瘤学中的列线图:远不止表面所见。
Lancet Oncol. 2015 Apr;16(4):e173-80. doi: 10.1016/S1470-2045(14)71116-7.

本文引用的文献

1
Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis.可切除食管癌新辅助化疗或放化疗后的生存:更新的荟萃分析。
Lancet Oncol. 2011 Jul;12(7):681-92. doi: 10.1016/S1470-2045(11)70142-5. Epub 2011 Jun 16.
2
A multicenter study of survival after neoadjuvant radiotherapy/chemotherapy and esophagectomy for ypT0N0M0R0 esophageal cancer.新辅助放化疗联合手术治疗 ypT0N0M0R0 期食管癌的生存多中心研究。
Ann Surg. 2010 Nov;252(5):744-9. doi: 10.1097/SLA.0b013e3181fb8dde.
3
A clinical nomogram predicting pathologic lymph node involvement in esophageal cancer patients.临床列线图预测食管癌患者的病理淋巴结转移。
Ann Surg. 2010 Oct;252(4):611-7. doi: 10.1097/SLA.0b013e3181f56419.
4
Improved outcomes in the management of esophageal cancer with the addition of surgical resection to chemoradiation therapy.手术切除联合放化疗可改善食管癌的治疗效果。
Ann Surg Oncol. 2011 Feb;18(2):551-8. doi: 10.1245/s10434-010-1314-7. Epub 2010 Sep 14.
5
Systematic review of the benefits and risks of neoadjuvant chemoradiation for oesophageal cancer.系统评价新辅助放化疗治疗食管癌的获益与风险。
Br J Surg. 2010 Oct;97(10):1482-96. doi: 10.1002/bjs.7175.
6
Influence of neoadjuvant chemoradiation on the number and size of analyzed lymph nodes in esophageal cancer.新辅助放化疗对食管癌分析淋巴结数量和大小的影响。
Ann Surg Oncol. 2010 Dec;17(12):3187-94. doi: 10.1245/s10434-010-1196-8. Epub 2010 Jun 29.
7
Optimum lymphadenectomy for esophageal cancer.食管癌的最佳淋巴结清扫术。
Ann Surg. 2010 Jan;251(1):46-50. doi: 10.1097/SLA.0b013e3181b2f6ee.
8
Histologic tumor type and the rate of complete response after neoadjuvant therapy for esophageal cancer.食管癌新辅助治疗后组织学肿瘤类型与完全缓解率。
Future Oncol. 2010 Jan;6(1):25-35. doi: 10.2217/fon.09.133.
9
Integrated FDG-PET/CT compared with intravenous contrast-enhanced CT for evaluation of metastatic regional lymph nodes in patients with resectable early stage esophageal cancer.18F-氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描(FDG-PET/CT)与静脉注射对比增强CT在可切除早期食管癌患者区域转移性淋巴结评估中的比较
Ann Nucl Med. 2009 Jan;23(1):73-80. doi: 10.1007/s12149-008-0209-1. Epub 2009 Feb 11.
10
Worldwide esophageal cancer collaboration.全球食管癌协作组织
Dis Esophagus. 2009;22(1):1-8. doi: 10.1111/j.1442-2050.2008.00901.x.

三模式治疗后食管癌患者手术标本中恶性淋巴结高概率相关的列线图。

A nomogram associated with high probability of malignant nodes in the surgical specimen after trimodality therapy of patients with oesophageal cancer.

机构信息

Department of Gastrointestinal Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, United States.

出版信息

Eur J Cancer. 2012 Dec;48(18):3396-404. doi: 10.1016/j.ejca.2012.06.020. Epub 2012 Jul 31.

DOI:10.1016/j.ejca.2012.06.020
PMID:22853875
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3869451/
Abstract

BACKGROUND

The presence of malignant lymph nodes (+ypNodes) in the surgical specimen after preoperative chemoradiation (trimodality) in patients with oesophageal cancer (EC) portends a poor prognosis for overall survival (OS) and disease-free survival (DFS). Currently, none of the clinical variables highly correlates with +ypNodes. We hypothesised that a combination of clinical variables could generate a model that associates with high likelihood of +ypNodes after trimodality in EC patients.

METHODS

We report on 293 consecutive EC patients who received trimodality therapy. A multivariate logistic regression analysis that included pretreatment and post-chemoradiation variables identified independent variables that were used to construct a nomogram for +ypNodes after trimodality in EC patients.

RESULTS

Of 293 patients, 91 (31.1%) had +ypNodes. OS (p=0.0002) and DFS (p<0.0001) were shorter in patients with +ypNodes compared to those with -ypNodes. In multivariable analysis, the significant variables for +ypNodes were: baseline T-stage (odds ratio [OR], 7.145; 95% confidence interval [CI], 1.381-36.969; p=0.019), baseline N-stage (OR, 2.246; 95% CI, 1.024-4.926; p=0.044), tumour length (OR, 1.178; 95% CI, 1.024-1.357; p=0.022), induction chemotherapy (OR, 0.471; 95% CI, 0.242-0.915; p=0.026), nodal uptake on post-chemoradiation positron emission tomography (OR, 2.923; 95% CI, 1.007-8.485; p=0.049) and enlarged node(s) on post-chemoradiation computerised tomography (OR, 3.465; 95% CI, 1.549-7.753; p=0.002). The nomogram after internal validation using the bootstrap method (200 runs) yielded a high concordance index of 0.756.

CONCLUSION

Our nomogram highly correlates with the presence of +ypNodes after chemoradiation, however, considerably more refinement is needed before it can be implemented in the clinic.

摘要

背景

在接受术前放化疗(三联疗法)的食管癌患者的手术标本中存在恶性淋巴结(+ypNodes),预示着总生存(OS)和无病生存(DFS)的预后不良。目前,没有任何临床变量与+ypNodes 高度相关。我们假设,临床变量的组合可以生成一个模型,该模型与三联疗法后食管癌患者发生+ypNodes 的可能性高度相关。

方法

我们报告了 293 例连续接受三联疗法的食管癌患者。多变量逻辑回归分析包括预处理和放化疗后变量,确定了独立变量,用于构建三联疗法后食管癌患者+ypNodes 的列线图。

结果

在 293 例患者中,91 例(31.1%)存在+ypNodes。与-ypNodes 相比,+ypNodes 患者的 OS(p=0.0002)和 DFS(p<0.0001)更短。多变量分析中,+ypNodes 的显著变量为:基线 T 期(优势比[OR],7.145;95%置信区间[CI],1.381-36.969;p=0.019)、基线 N 期(OR,2.246;95%CI,1.024-4.926;p=0.044)、肿瘤长度(OR,1.178;95%CI,1.024-1.357;p=0.022)、诱导化疗(OR,0.471;95%CI,0.242-0.915;p=0.026)、放化疗后正电子发射断层扫描(PET)的淋巴结摄取(OR,2.923;95%CI,1.007-8.485;p=0.049)和放化疗后计算机断层扫描(CT)的肿大淋巴结(OR,3.465;95%CI,1.549-7.753;p=0.002)。内部验证使用自举法(200 次运行)后生成的列线图具有 0.756 的高一致性指数。

结论

我们的列线图与放化疗后+ypNodes 的存在高度相关,但在临床应用之前还需要进一步细化。